Filing Details
- Accession Number:
- 0001104659-12-043247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-13 13:11:46
- Reporting Period:
- 2012-06-11
- Filing Date:
- 2012-06-13
- Accepted Time:
- 2012-06-13 13:11:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008170 | F Leland Wilson | 1172 Castro Street Mountain View CA 94040 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-06-11 | 23,880 | $4.15 | 142,992 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-11 | 23,880 | $25.18 | 119,112 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-06-11 | 26,120 | $4.15 | 145,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-11 | 26,120 | $25.18 | 119,112 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-06-11 | 23,880 | $0.00 | 23,880 | $4.15 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-06-11 | 26,120 | $0.00 | 26,120 | $4.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-24 | No | 4 | M | Direct | |
| 50,000 | 2015-01-24 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2010.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $25.00 to $25.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- Includes 841 shares acquired on May 14, 2012 under the VIVUS, Inc. Employee Stock Purchase Plan.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
